Amendment to the September 29, 2022 Employment Agreement between Celularity Inc. and Adrian KilcoyneEmployment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations
Contract Type FiledFebruary 22nd, 2024 Company IndustryThis Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and Adrian Kilcoyne, MD (“Executive”) (collectively the “Parties”).
Amendment to the April 1, 2022 Amended and Restated Employment Agreement between Celularity Inc. and David BeersEmployment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations
Contract Type FiledFebruary 22nd, 2024 Company IndustryThis Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and David Beers (“Executive”) (collectively the “Parties”).
Amendment to the July 13, 2022 Employment Agreement between Celularity Inc. and K. Harold FletcherEmployment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations
Contract Type FiledFebruary 22nd, 2024 Company IndustryThis Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and K. Harold Fletcher (“Executive”) (collectively the “Parties”).
Amendment to the April 1, 2022 Amended and Restated Employment Agreement between Celularity Inc. and Stephen BrigidoEmployment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations
Contract Type FiledFebruary 22nd, 2024 Company IndustryThis Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and Stephen A. Brigido, DPM (“Executive”) (collectively the “Parties”).
Amendment to the April 1, 2022 Amended and Restated Employment Agreement between Celularity Inc. and John HainesEmployment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations
Contract Type FiledFebruary 22nd, 2024 Company IndustryThis Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and John R. Haines (“Executive”) (collectively the “Parties”).
Second Amendment to the January 7, 2021 Amended and Restated Employment Agreement between Celularity Inc. and Robert J. Hariri, MD PhDEmployment Agreement • February 22nd, 2024 • Celularity Inc • Pharmaceutical preparations
Contract Type FiledFebruary 22nd, 2024 Company IndustryThis Amendment Agreement (“Agreement”) is entered into by and between Celularity Inc. (the “Company”) and Robert J. Hariri, MD, PhD (“Executive”) (collectively the “Parties”).